Parametrica Management’s Gilead Sciences GILD Stock Holding History

Parametrica Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-20,728	Closed	-$1.55M	–	187
2020 Q1	$1.55M	Buy	+20,728	New	+$1.43M	1.56%	11
2019 Q1	–	Sell	-12,009	Closed	-$751K	–	229
2018 Q4	$751K	Buy	+12,009	New	+$839K	0.92%	5
2018 Q1	–	Sell	-4,123	Closed	-$295K	–	297
2017 Q4	$295K	Buy	+4,123	New	+$313K	0.19%	203

Other funds holding GILD

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Parametrica Management's GILD Position: Q2 2020 in Review

Parametrica Management sold out of Gilead Sciences (GILD) in Q2 2020, closing a stake of 20,728 shares — an estimated $1.55M sold.

Parametrica Management first reported a position in GILD in Q4 2017 and held it in 3 quarters. The position peaked at $1.55M in Q1 2020. 1,626 funds tracked by Wall St. Rank hold GILD as of Q2 2020.

Parametrica Management reported no remaining Gilead Sciences position as of Q2 2020 after selling out during the quarter.
Parametrica Management sold 20,728 Gilead Sciences shares in Q2 2020, an estimated $1.55M.
Parametrica Management first reported a position in Gilead Sciences in Q4 2017 and held it in 3 quarters.
Parametrica Management's Gilead Sciences position peaked at $1.55M in Q1 2020.
1,626 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2020.

Based on Parametrica Management's 13F filing for Q2 2020, filed 17 Aug 2020.